Sarah Ebstein (S Y Ebstein)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 3

Top Topics

Immune Response

Replacement Therapy

Diffuse Large B Cell Lymphoma

Top Venues

Science translational medicine

Science immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Sarah Ebstein, A Rafique, Y Zhou, A Krasco, W Montalvo-Ortiz, L Yu, L Custodio, R C Adam, N Bloch, K Lee, F Adewale, D Vergata, A Luz, S Coquery, B Daniel, E Ullman, M C Franklin, A Hermann, T Huang, W Olson, S Davis, A J Murphy, M A Sleeman, J Wei, D Skokos
VSIG4 interaction with heparan sulfates inhibits VSIG4-complement binding. Glycobiology (2023)
Joyce Wei, Welby Montalvo-Ortiz, Lola Yu, Amanda Krasco, Sarah Ebstein, Czrina Cortez, Israel Lowy, Andrew J Murphy, Matthew A Sleeman, Dimitris Skokos
Sequence of αPD-1 relative to local tumor irradiation determines the induction of abscopal antitumor immune responses. Science immunology 6 (58) (2022)
Joyce Wei, Welby Montalvo-Ortiz, Lola Yu, Amanda Krasco, Kara Olson, Sahar Rizvi, Nathalie Fiaschi, Sandra Coetzee, Fang Wang, Erica Ullman, Hassan Shakil Ahmed, Evan Herlihy, Ken-Wing Lee, Lauren Havel, Terra Potocky, Sarah Ebstein, Davor Frleta, Aditi Patel, Stephen Godin, Sara Hamon, Jurriaan Brouwer-Visser, Travis Gorenc, Douglas MacDonald, Aynur Hermann, Aafia Chaudhry, Andres Sirulnik, William C Olson, John Lin, Gavin Thurston, Israel Lowy, Andrew J Murphy, Eric Smith, Vladimir Jankovic, Matthew A Sleeman, Dimitris Skokos
CD22-targeted CD28 bispecific antibody enhances antitumor efficacy of odronextamab in refractory diffuse large B cell lymphoma models. Science translational medicine 14 (670) (2022)